
Mr. Oliver Ball
Oliver has experience in life sciences translation consulting, and has previously worked as an independent consultant. He graduated from King's College London with an MSc in 'Cellular Therapy from Bench to Market' in August 2016, following a BSc in Biomedical Sciences from the University of Kent. He has authored several industry reports, supported the establishment of an industry-academia partnership in the Centre for Stem Cells and Regenerative Medicine at King's College London, and sat on the TERMIS-BPC organising committee for 2016/17.

Mr. Shiraz Ziya
Shiraz completed his PhD research at the RJAH Orthopaedic Hospital NHS Foundation Trust with Keele University, in partnership with Loughborough University, through the EPSRC Doctoral Training Centre in Regenerative Medicine. His research explored the feasibility of delivering personalised cell-based therapy as a service within the NHS. Shiraz has a keen interest in establishing cross-sector collaboration to support healthcare innovation and is a major driving force behind TERMIS-EU BPC’s Pre-Accelerator Programme.

Dr. Sujit Kootala
Sujit is a postdoctoral researcher at University of Pau & Pays de l'Adour, France. His research focusses on the development of smart materials for tissue engineering and drug delivery applications. He develops tools to functionalise natural polymers to direct cell response and fate in living systems with applications in bone tissue engineering, nerve repair and smart drug delivery systems for cancer. Sujit is active in TERMIS and European Society for Biomaterials in developing bridges between researchers in both societies. He is keen to develop and strengthen local feeders to TERMIS that will channelise innovative developments from local levels to larger platforms such as TERMIS.

Mr. Erik Samuelsson
Doctoral Student in Biochemistry at Stockholm University
Committee Advisors

Dr. Chris Gemmiti
Chris is the Business Development Lead at Wyss Institute for Biologically Inspired Engineering at Harvard University and the Founder & Managing Director of Ridgewood Consulting LLC. Having helped develop the TERMIS-AM BPC, he has been advising the TERMIS-EU BPC Committee since its foundation in order to ensure its success.

Dr. MacKenna Roberts
MacKenna is an IP lawyer and strategic adviser for the translation of biomedical technologies. Her legal experience spans IP technology disputes to privacy, data protection and breach of confidentiality matters.

Dr. Suzanne Tabbaa
Suzanne is a Market Development Manager at NuVasive Inc. for their orthobiologics products. Her role spans the technical knowledge and market development components of NuVasive’s Biologics portfolio. Prior to joining NuVasive, Suzanne worked as researcher in a joint role between the University of California, San Diego and Colorado State University where she led the development and early stages of commercialization for a cartilage repair technology. Suzanne completed her PhD in Bioengineering at Clemson University where she gained experience and training in the business canvas model, working with start-ups, and competing as a finalist in numerous business plan competitions including the TERMIS World BPC.
Committee Alumni

Dr. Christopher Tse

Ms. Zhen Cahilog

Dr. Nick J Walters

Dr. Richard Balint

Dr. Sybil Wong

Ms. Wenting Gu

Prof. Martin Stoddart

Dr. Gui Zhen (Cheryl) Teoh

Ms. Shujiang Wang

Mr. Pravesh Gupta

Ms. Tracy Yu

Dr. Julien Barthes
Ambassadors
If you are an early career academic interested in entrepreneurship, we would love to work with you! We are currently seeking national ambassadors from across the world, to promote BPC and PAP activities within their country’s research institutes and companies.
To apply to become an Ambassador, send your CV along with a letter of motivation to [email protected].